Overview

Efficacy of Dapsone as a Steroid Sparing Agent in Pemphigus Vulgaris

Status:
Terminated

Trial end date:
2004-02-01

Target enrollment:

Participant gender:

Summary

The purpose of this 12-month study was to determine the efficacy of dapsone as a glucocorticoid-sparing agent in maintenance phase pemphigus vulgaris.

Phase:

Phase 2

Details

Lead Sponsor:

Jacobus Pharmaceutical

Treatments:

Dapsone